Fig. 2From: Anemia in patients ≥ 75 years with metastatic clear cell renal cell carcinoma: an important poor prognostic factor in the international metastatic renal cell carcinoma database consortium modelSankey diagrams showing treatment flow. First- to second-line treatment flow in mRCC patients (A) ≥ 75 years and (B) < 75 years. Elderly patients were more likely to receive BSC instead of active second-line therapyBack to article page